Clinical Trials
2 trialsNCT00611208 2016-11-29
A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL)
Virogen Biotechnology Inc.
Phase 2 Completed
NCT00001249 2008-03-04
Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) With Yttrium-90 Radiolabeled Anti-Tac
National Institutes of Health Clinical Center (CC)
Phase 1 Completed